Antifungal drug may tame Crohn's after surgery
NCT ID NCT02997059
First seen Apr 23, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study tested whether the antifungal drug fluconazole could lower certain antibodies (ASCA) and prevent Crohn's disease from coming back after bowel surgery. 35 adults with Crohn's disease who had recent ileal or ileocecal resection were randomly assigned to receive fluconazole or a placebo for 6 months. The goal was to see if targeting a common yeast in the gut could reduce inflammation and recurrence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE AGGRAVATED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU, Hôpital Claude Huriez
Lille, France
Conditions
Explore the condition pages connected to this study.